Skip to main content

Table 3 Graft details and donor microchimerism rate after GPBSC infusion

From: HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center

Patient

Graft

Donor microchimerism rate (%)

aGVHD

Mononuclear (cells/kg)

CD34+ (cells/kg)

1 week

2 weeks

3 weeks

4 weeks

Organ system affected

Severity scoring

1

12.2

4.56

37.4

86.0

93.89

 

Elevated LFTs, rash, GI symptoms

IV

2

5.5

2.31

0.024

0.081

    

3

9.7

2.115

0.023

0.014

0.005

   

4

5.5

2.59

     

5

5.1

1.17

0.846

0.148

  

Elevated LFTs, GI symptoms

II

6

5.2

2.08

0.17

   

Elevated LFTs, GI symptoms

II

7

6.4

1.4

     

8

11.6

2.43

0.15

0.25

    

9

10.1

2.4

   

GI symptoms

I

10

9.7

4.924

11.21

0.15

0.01

0.01

Elevated LFTs, GI symptoms

II

11

16.4

3.19

     

12

5.3

1.325

0.002

0.001

  

Elevated LFTs

I

13

9.6

3.11

0.008

     

14

6.1

2.04

     

15

8.8

2.65

     

16

16.5

2.31

0.37

0.31

0.034

   

17

5.1

2.448

     

18

5.7

1.824

3.26

0.76

  

Elevated LFTs, GI

II

  1. LFT liver function test, GI gastrointestinal